Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹863.75
Market cap: ₹16,978 Cr
Revenue (annual): ₹7,345 Cr
Net profit (annual): ₹674.8 Cr
P/E (TTM): 24.5×Sector 50.4×
Promoter holding: 69.87%+0.13% QoQ
FII holding: 4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Debt & Borrowing 3 Merger & Restructuring 2 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

7 Sep 2026 20:43 IST BSE

Merger & Restructuring

Alembic Pharmaceuticals Merger & Restructuring Worth ₹0.26 Cr

Alembic Pharmaceuticals incorporated a wholly owned subsidiary, Alembic Pharmaceuticals Global FZCO, in the UAE for Rs. 0.26 Crore to explore new business opportunities in pharmaceuticals.

Value: ₹0.26 Cr

Read the filing ↗

7 Sep 2026 20:33 IST BSE

Merger & Restructuring

Alembic Pharmaceuticals Merger & Restructuring Worth ₹0.25 Cr

Alembic Pharmaceuticals incorporated a wholly owned subsidiary, Alembic Pharmaceuticals Global FZCO, in Dubai to explore new business opportunities and distribution.

Value: ₹0.25 Cr

Read the filing ↗